title: Pain and chronic pancreatitis: is it the plumbing or the wiring?
abstract: Our progress in understanding the biology of chronic pancreatitis has been slow, particularly with respect to the pathogenesis of pain, the cardinal symptom. Although traditional theories have focused on anatomic changes, with interstitial and ductal hypertension as the main inciting factors for pain generation, subsequent studies have not confirmed a correlation between ductal pressure and the severity of pain or its relief after ductal decompression. Empirical approaches directed at anatomic causes are at best of marginal value. Although these phenomena are clearly associated with the disease, they are not likely the root cause of the pain. Instead, they probably are inciting factors on a background of neuronal sensitization induced by damage to the perineurium and subsequent exposure of the nerves to mediators and products of inflammation. In this review, we discuss the inherent limitations in our current therapies and try to identify new targets and approaches for the future, such as TRPV1, nerve growth factor-TrkA signaling, and perhaps protease activator receptor-2.
authors.affiliation: Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 300 Pasteur Drive, Alway Building, Room M211, Stanford, CA 94305, USA.
authors.forename: Rajeswari
authors.initials: R
authors.lastname: Anaparthy
authors.forename: Pankaj Jay
authors.initials: PJ
authors.lastname: Pasricha
mesh_terms: D015746:Abdominal Pain / Q000209:etiology / Q000503:physiopathology; D019299:Decompression, Surgical / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D009407:Nerve Block / Q000379:methods; D010147:Pain Measurement; D010148:Intractable Pain / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D010183:Pancreatic Ducts / Q000503:physiopathology; D010184:Pancreatic Extracts / Q000627:therapeutic use; D050500:Pancreatitis, Chronic / Q000150:complications / Q000175:diagnosis*; D011379:Prognosis; D044464:Receptor, PAR-2 / Q000627:therapeutic use; D020917:Receptor, trkA / Q000627:therapeutic use; D050916:TRPV Cation Channels / Q000187:drug effects; D016896:Treatment Outcome
chemical_list: D010184:Pancreatic Extracts; D044464:Receptor, PAR-2; D050916:TRPV Cation Channels; D020917:Receptor, trkA